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Abstract: With the aim of exploiting the use of organo-
metallic species for the efficient modification of proteins
through C-atom transfer, the gold-mediated cysteine aryl-
ation through a reductive elimination process occurring
from the reaction of cyclometalated AuIII C^N complexes
with a zinc finger peptide (Cys2His2 type) is here reported.
Among the four selected AuIII cyclometalated compounds,
the [Au(CCON)Cl2] complex featuring the 2-benzoylpyridine
(CCON) scaffold was identified as the most prone to reduc-
tive elimination and Cys arylation in buffered aqueous so-
lution (pH 7.4) at 37 8C by high-resolution LC electrospray
ionization mass spectrometry. DFT and quantum mechan-
ics/molecular mechanics (QM/MM) studies permitted to
propose a mechanism for the title reaction that is in line
with the experimental results. Overall, the results provide
new insights into the reactivity of cytotoxic organogold
compounds with biologically important zinc finger do-
mains and identify initial structure–activity relationships to
enable AuIII-catalyzed reductive elimination in aqueous
media.
Selective biomolecule modification is an important chemical
biology tool for manipulating the properties of biomolecules
and investigating their functions in complex biological sys-
tems.[1] Transition-metal complexes render numerous new or-
ganic transformation reactions possible and have been exten-
sively used in organic synthesis. Recently, promising strategies
have been developed to apply transition-metal complexes to
bioconjugation. The peculiar reactivity and selectivity of such
complexes significantly broaden the scope of the chemical re-
action tool boxes for biomolecule modification.[2] Thus, the
past decade has witnessed new ways of tagging proteins with
fluorophores or other probes based on palladium-mediated re-
actions that played a major role in modern organic synthesis,
such as the Suzuki–Miyaura, Mizoroki–Heck, and Sonogashira
cross-coupling reactions.[3]
Although quite attractive, the palladium-mediated creation
of C@C or C@X bonds involving proteins inside living cells as
coupling partners remains challenging, being plagued by un-
productive interactions of the complex with endogenous func-
tional groups, as in the case of copper-mediated bioconju-
gation processes.[4] To address these limitations, efforts have
been made to design transition-metal complexes of reduced
fragility in the biological milieu, including the use of palladium
nanoparticles.[5]
In this context, gold complexes have also emerged as ex-
tremely promising, being endowed with excellent reactivity
and selectivity, compatibility with aqueous reaction medium,
and mild reaction conditions.[6, 7] Following the strategy of in-
troducing aryl moieties in proteins with the aid of aryl transi-
tion-metal reagents, Wong and co-workers have tackled the
possibility of forming C@S bonds by derivatizing the sulfhydryl
group in cysteines,[8] as an alternative to the N-methylmale-
imide cysteine ligation, given the lack of stability in physiologi-
cal environments of the maleimide adducts.[9]
In proof-of-concept experiments, exposure of different pep-
tidic domains at 37 8C for 24 h to an equimolar amount of the
AuIII C^N complex A, featuring a N,N’-bis(methanesulfonyl)-
ethylene ancillary ligand (Figure 1), produced remarkable con-
versions in the corresponding aryl thioethers.[8] Under these
conditions, the reaction did not stop at the gold–peptide ad-
ducts, but produced the arylated product resulting from C@S
reductive elimination. The excellent chemoselectivity of the re-
action was further demonstrated in bioconjugation reactions
targeting the surface exposed cysteine residue of serum albu-
min, with the aid of a dansyl-linked AuIII C^N derivative of A.[8]
With the aim of developing selective protein binders, the se-
lectivity of AuIII C^N complexes to the zinc finger domain of
PARP-1 was studied using a hyphenated mass spectrometry
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approach combined with quantum mechanics/molecular me-
chanics (QM/MM) studies.[10] The nature of the AuIII peptide
bound fragments was identified, and under the applied experi-
mental conditions the most reactive and selective compound
1 [Au(CCH2N)Cl2] formed mainly peptide-[Au
IIICCH2N)] adducts.
Notably, the compound showed, in competition experiments,
the highest selectivity for the cysteine-rich zinc finger PARP-1
(Cys2HisCys type) with respect to the Cys2His2 type of
domain.[10]
The reported binding selectivity towards a specific zinc
finger domain could never be observed for AuIII coordination
complexes featuring chelating N^N ligands;[11, 12] therefore,
highlighting the great potential of organometallic AuIII C^N
complexes as targeted protein binders.
More recently, Farrell and co-workers have further described
the reaction of the AuIII C^N complex 1 with the full-length
zinc finger (Cys3His) of HIV nucleocapsid protein NCp7 result-
ing in C@S aryl transfer from the AuIII organometallic species to
a cysteine of the zinc finger.[13] The Cys arylation was observed
by mass spectrometry after 48 h incubation with the peptide.
Intrigued by these observations, we decided to further ex-
plore the reactivity of AuIII C^N complexes with a model of
Cys2His2 zinc finger domain (ZF). The library of compounds was
expanded to include 1, 2 [Au(CNHN)Cl2] (C
NHN=N-phenylpyr-
idin-2-amine,) and 3 [Au(CCON)Cl2] (C
CON=2-benzoylpyridine)
(Figure 1) with the aim to gain more insight into the factors
controlling the key C@S coupling reaction. Each gold complex
was incubated separately with the ZF peptide in a 3:1 ratio in
(NH4)2CO3 buffer (25 mm, pH 7.4) and the samples analyzed at
different incubation times (10 min and 24 h at 37 8C) by high-
resolution electrospray ionization mass spectrometry (HR-LC-
ESI-MS) following previously reported procedures.[10] The MS
studies were further supported by circular dichroism (CD) spec-
troscopy, which confirmed the proper folding of the holo-ZF
domain[14] as well as the loss of the typical secondary structure
upon addition of complex 3 in buffered aqueous solution (Fig-
ure S1, Supporting Information).
The HR-LC-ESI-MS results showed that all compounds react
quickly, but distinctively, with the ZF domain by displacing zinc
from the coordination site. After 10 min, all three complexes
form classical apo-ZF-[AuIII(C^N)] adducts, and two or even
three of these adducts can be detected, demonstrating the
presence of multiple Au binding sites (Table S1 and Figures
S2–S4, Supporting Information). Only complex 3 induced cys-
teine arylation forming also apo-ZF-[CCON] species as a result of
C@S reductive elimination (Table S1, Figure S4, Supporting In-
formation).
Figure 2 reports the HR-LC-ESI-MS spectra obtained for com-
plexes 1–3 after 24 h incubation with the ZF domain. At longer
incubation times, the results show the coexistence of apo-ZF-
Figure 1. Structure of the cyclometalated AuIII C^N complexes A and 1–4
studied for their Cys arylation properties.
Figure 2. HR-LC-ESI-MS spectra of the reaction of AuIII C^N complexes 1–3 with the Zn–ZF domain (3:1 ratio) after 24 h incubation at 37 8C in (NH4)2CO3
buffer (25 mm, pH 7.4). Comparisons between experimental and theoretical isotopic pattern distribution for selected adducts. In each simulated isotopic distri-
bution Au ions were considered in the oxidation state 3+ . The ZF sequence is 1PYKCPECGKSFSQKSDLVKHQRTHTG26.
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[AuIII(C^N)] adducts and arylation products apo-ZF-[C^N]. In
the case of 3, the MS spectrum shows the presence of an
adduct of the type [apo-ZF+3(CCON)]n+ at m/z 584.7598 (n=
6), indicating the existence of up to three arylation sites on the
peptide. It is likely that in excess of metal complex, amino acid
side chains other than those of the two Cys, may be arylated.
In previous tandem MS/MS experiments, we assessed the likely
binding sites for compound 1 on the ZF model.[10] Specifically,
the fragmentation pattern of the apo-ZF-[AuIIICCH2N] adduct
suggested AuIII coordination to Cys4 and Cys7 as well as to
His24. Thus, the nitrogen of His24 may be another arylation
site. In fact, AuIII–aryl species have been unequivocally identi-
fied as reactive intermediates in oxidant-free C@N cross cou-
pling reactions.[15,16] Overall, in the present study, the analysis
of the reaction products indicates that 3 is the most prone to
reductive elimination, followed by 1 and 2. The latter is also
the one forming mainly mono-adducts apo-ZF-[AuIII(CNHN)] .
Afterwards, the five-membered cyclometalated AuIII complex
4 [Au(phepy)Cl2] (phepy=2-phenyl-pyridinato) was also tested
to investigate the influence of a different C^N scaffold on the
reactivity with the ZF. In this case, the complex formed mainly
mono-adducts of the type ZF-[AuIII(C^N)] already after 10 min
incubation, which remained stable after 24 h (Table S1 and Fig-
ure S5, Supporting Information). No indication of any reductive
elimination products could be detected.
It is worth mentioning that when we repeated the experi-
ments under the same conditions, but reacting the com-
pounds with Cys instead of the ZF domain, we were not able
to detect any Cys arylation product (data not shown), in line
with previously reported studies.[17] This result indicates that
for the reductive elimination to take place following AuIII-thiol
adduct formation, the entire metal complex-peptide adduct is
crucial. We surmised that the peptide provides multiple gold
binding sites which template the arylation reaction.
Reductive elimination plays a major role in transition-metal-
mediated reactions (cross-couplings in particular). It is the key
product-releasing step of many transformations. In contrast to
oxidative addition, the feasibility of reductive elimination at
gold has never been questioned and it was demonstrated ex-
perimentally early on.[6] Nevertheless, our knowledge on reduc-
tive elimination at gold remains rather limited, especially for
reactions arising in aqueous environment, and involving pep-
tides as substrates.[18]
Thus, to rationalize the results of the experimental investiga-
tions, DFT calculations were performed with complexes 1–4.
Due to the strong preference for reductive elimination to
occur between groups located in cis position, it is very likely
that the cysteine arylation involves AuIII C^N complexes as key
intermediates with the aryl group and a cysteinate in cis ar-
rangement. It must be noted that previously reported results
by tandem MS identified Cys4 as the most stable Au binding
site for complexes 1 and 2 in the selected ZF domain.[10] Thus,
our mechanistic hypothesis, according to which at least one of
the chlorido ligands is replaced by a cysteinate prior to reduc-
tive elimination, is in line with the experimental observation.
Due to the high electronic dissymmetry of the C^N chelate
(C exerts a much stronger trans influence than N),[6, 15] the cys-
teinate adduct with S in trans position to N (and thus, cis to
the aryl group) is more favored thermodynamically. This stereo-
chemical preference has been supported experimentally in re-
lated thiolate complexes,[19] and the difference in energy with
the other diastereomer is large according to DFT calculations
(see Figure S6 and Table S2 in the Supporting Information, and
Ref. [10] and [20]).
The hypothesized mechanism for C@S coupling is depicted
in Scheme 1. In the cysteinate AuIII complex with the chelate
C^N ligand (R), the aryl group is almost coplanar with the gold
coordination plane, thus, coupling with the adjacent S atom is
disfavored.[21] For the aryl group to participate in reductive
elimination, it must rotate. This requires the N atom to decoor-
dinate and the C^N chelate to open. To promote this process,
the participation of a second cysteinate residue is envisioned.
Apical approach of the S atom induces the displacement of
the N atom from gold and leads to the bis-cysteinate adduct I
via transition state TS1. Reductive elimination then proceeds
via transition state TS2 to give the Cys-arylated product P and
the linear AuI complex [CysAuCl]@ . Complexes 1–3 present
phenyl and 2-pyridyl scaffolds linked by CH2, NH and CO
groups, respectively, whereas the C^N ligand of compound 4
is a 2-phenyl-pyridinate, that is, with no linker group between
the two aromatic groups.
The species involved and their relative energy values, for the
more reactive AuIII compound 3, with carbonyl as bridging
group in the chelating ligand, are shown in Figure 3A. Analo-
gous figures are reported for compounds 1, 2 and 4 in the
Supplementary Information (Figures S7–S9, Supporting Infor-
mation). The relative energy values and activation barriers are
reported in Table 1. The relative energies along the reaction
pathways for the four AuIII complexes are graphically compared
in Figure 3B. Rather similar reaction profiles were obtained for
the three complexes 1–3. The displacement of the pyridine
moiety by cysteinate at gold (first step leading to I) is exergon-
ic (by 32.4–63.5 kJmol@1) and proceeds with a low energy bar-
rier (7.9–29.4 kJmol@1). The subsequent reductive elimination is
favored thermodynamically and appears to be the rate-deter-
Scheme 1. Proposed reaction mechanism for the cysteine arylation reaction
(C@S coupling) catalyzed by the AuIII C^N complexes.
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mining step with activation barriers of 47.3–75.8 kJmol@1.
Closer inspection reveals small but significant differences be-
tween the three related C^N ligands. For example, the TS1
energy values for compounds 2 and 3 are 29.4 vs. 7.9 kJmol@1,
respectively. This result suggests that the first reaction step is
consistently faster for 3 compared to 2, in agreement with the
higher propensity to give reductive elimination of the former
complex. Moreover, the activation barrier for the C@S coupling
(E2
*) increases in the order CO(3)<CH2 (1)<NH(2). This trend
well explains why, in the HR-LC-ESI-MS experiments, cysteine
arylation easily occurs with 3, much less with 1, and only after
24 h for 2.
As apparent from Figure 3B, the difference between com-
pounds 1–3 results from the stability of the bis-cysteinate in-
termediate I as compared to the starting complex R. This inter-
mediate is less stable with the CO bridging unit and in turn,
the following transition state TS2 is very accessible in energy,
which results in a small energy span.
The phenyl-pyridine complex 4 shows a slightly different re-
action energy profile (Figure S9, Supporting Information). The
bis-cysteinate intermediate I is comparable in energy to the
starting complex R. The stronger chelating effect compared to
the C^N ligands disfavors N decoordination, but the corre-
sponding activation barrier remains fairly accessible
(22.2 kJmol@1). The low stability of intermediate I could have
resulted in a low energy span and overall easy cysteine aryla-
tion process, by extension of that observed for the C^N li-
gands. However, the transition state TS2 for reductive elimina-
tion lies quite high in energy and the activation barrier for C@S
coupling is significantly higher than for complex 3
(63.2 kJmol@1). One possible explanation may be the higher
steric demand nearby the C atom of the aryl group to be cou-
pled with the cysteinate residue. In fact, the pyridyl ring is di-
rectly linked to the phenyl moiety and may induce some steric
shielding. The reaction profile is consistent with the experi-
mental results of complex 4 in which no sign of cysteine aryla-
tion has been detected. Enlarged structures of the transition
states and of the intermediate of all compounds are reported
in Figures S10 and S11 (Supporting Information).
The observed differences in the relative stability of R and I
cannot be simply attributed to the electronic effects the bridg-
ing unit exerts on the N atom of the pyridine. Indeed, the
withdrawing character of the C=O bridge is expected to de-
crease the donor strength of N. Therefore, decoordination
from the AuIII center should be more favored thermodynam-
ically for the NCOC ligand, which is not the case. Other factors
probably come into play to explain the influence of the C^N
ligand. This could involve the p-conjugation within the differ-
ent C^N frameworks and how it is affected for the different li-
gands upon N decoordination (from R to I). To evaluate the dif-
ferent donicity of the pyridine nitrogen atom and the p-conju-
gative strengths, natural bond orbital (NBO) analyses were per-
formed on the starting complexes deriving from 2 and 3 (Fig-
ure S12, Supporting Information). Furthermore, we also
evaluated possible differences due to steric effects by using
non-covalent interaction (NCI) plots (Figure S13, Supporting In-
formation). Unfortunately, the obtained results do not allow for
an unambiguous identification of the differences in steric and/
or electronic effects and/or in weak non-covalent interactions
that could explain the different relative stability of the inter-
mediates.
Afterwards, QM/MM calculations were performed to mimic
the binding of compound 3 with the ZF domain, and the
structure assumed by the system along the reaction pathway.
The higher QM layer is composed by 3 and by the Cys35 and
Cys38 residues (atoms in balls and sticks in Figure 3C).
The structures of the transition states involved are reported
in Figure S14 (Supporting Information) and their energy values
shown in the plot of Figure 3B. It is interesting to notice that
the relative Gibbs free energy values of reactant, intermediate,
and product are comparable with those obtained for the
model systems reported in Scheme 1 and in Figure 3A,B.
Figure 3. A) species involved along the reaction pathway of the most reac-
tive compound [Au(CCON)Cl2] 3, containing the C=O bridging group in the
chelating ligand; structure and energies were obtained by DFT calculations.
B) Comparison of the relative energy profiles calculated for the four AuIII
C^N compounds 1–4 ; activation energies (E1
* and E2
*, in kJmol@1) of the
first and second reaction steps are indicated for each bridging group in the
chelating ligand. C) Structures of the adduct of 3 with the ZF (3-ZF), R, I and
P, obtained by QM/MM calculations, with relative energy values also shown
in magenta in panel B. The atoms in the lower MM layer are represented in
wires. The protein backbone is highlighted in unstructured tube and alpha
helix styles.
Table 1. Calculated relative standard Gibbs free energy values and the
first and second activation barriers (kJmol@1) of the species involved in
the proposed reaction pathway of the considered AuIII C^N compounds
1–4.
Compounds
1 2 3 4 3/ZF
R 0.0 0.0 0.0 0.0 0.0
TS1=E1
* 12.7 29.4 7.9 22.2 4.1
I @63.5 @54.4 @32.4 5.4 @36.2
TS2 @6.1 21.4 14.8 69.2 37.2
E2
* 57.4 75.8 47.3 63.8 73.4
P @114.8 @89.5 @89.2 @63.7 @81.3
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Cysteine bioconjugation is a powerful tool that allows for
the introduction of a diverse array of substrates to biomole-
cules through formation of covalent linkages. With the aim of
expanding the scope, generality and utility of transition-metal-
mediated thiol arylation through C@S bond formation, reduc-
tive elimination processes occurring from robust organometal-
lic AuIII complexes have been recently described by some au-
thors,[21] although only few have explored this reactivity in
physiologically relevant conditions.[8, 22]
In summary, we have further explored the potential of C^N-
cyclometalated AuIII complexes for Cys arylation in protein do-
mains, considering that this reactivity is noteworthy for the
ZnCys2His2 transcription factors. Thus, we have identified initial
structure–activity relationships to direct the reactivity of this
family of gold complexes towards a certain zinc finger domain,
which may lead to controlled reductive elimination in aqueous
environment. Moreover, specificity and efficiency in gold–
ligand binding and subsequent C@S transfer may be modulat-
ed both by the nature of the gold compound and the nucleo-
philicity and accessibility of the cysteines in the zinc finger
core.[23] The latter contribution may also explain why we could
not find any evidence of reductive elimination in the case of
the PARP-1 zinc finger peptide.[10] Further studies are necessary
to fully explore the electronic and steric effects of different li-
gands on the arylation process, as well as to consider the ef-
fects of the protein microenvironment on the stability of the
intermediates, possibly influenced by other non-covalent inter-
actions between the metal complex and the peptide.
Experimental Section
General
Solvents and reagents (reagent grade) were all commercially avail-
able and used without further purification. The zinc finger precur-
sor peptides were obtained from Peptide Specialty Laboratories
GmbH and had the sequence 1PYKCPECGKSFSQKSDLVKHQRTHTG[26]
(ZF). Ammonium carbonate, dimethyl sulfoxide (DMSO), zinc ace-
tate dihydrate, water (molecular biology grade) were purchased
from Fisher. Dithiothreitol (DTT) was purchased from Alfa Aesar. 1H
and 13C NMR spectra were recorded in [d6]DMSO solution, with
TMS as the internal reference, on Bruker Avance 400 or 500 MHz
NMR spectrometers. HR-ESI-MS spectra were recorded on Synapt
G2-Si time-of-flight (TOF) mass spectrometer (Waters) by high-pres-
sure liquid chromatography (HPLC). HPLC was performed with an
Acquity UPLC system (Waters) and by using an Acquity UPLC pro-
tein BEH C4 column (300 a, 1.7 mm, 2.1 mmV100 mm). Mass spec-
tra were acquired and processed using MassLynx V4.1 (Waters).
Compounds 1–4 have been synthesized by following procedures
already reported in the literature.[19,24] The purity of the compounds
was confirmed by elemental analysis, which showed purity >98%.
Mass spectrometry studies
The zinc finger was reconstituted according to a previously pub-
lished procedure.[12] In brief, the precursor peptide was incubated
with DTT (3 equiv, 3 h) in (NH4)2CO3 (25 mm, pH 7.4) and then with
zinc acetate (3 equiv, 30 min) at 37 8C. The formation of the zinc
finger was assessed by a mass shift in the resulting mass spectra.
Stock solutions of the gold compounds were freshly prepared in
DMSO at a concentration of 10 mm. The individual experiments be-
tween the gold compounds and the ZF were performed at a molar
ratio of 3:1 (gold complex:ZF) with the peptide at a final concen-
tration of 10 mm. The compounds were typically incubated at 37 8C
for 10 min and 24 h. Samples were analyzed with a Synapt G2-Si
time-of-flight (TOF) mass spectrometer (Waters). The instrumental
parameters for high-pressure liquid chromatography mass spec-
trometry (HPLC-MS) were as follows: 2.85 kV capillary voltage,
120 8C source temperature, 350 8C desolvation temperature,
90 Lh@1 cone gas, 900 Lh@1 desolvation gas and 6 bar nebulizer. A
linear gradient from 95 to 5% water [0.1% formic acid (FA)] ,
whereas proportionally increasing acetonitrile (0.1% FA), in 8 min
was used. The flow rate was 300 mLmin-1, the column was held at
40 8C and the autosampler at 20 8C.
Circular dichroism
Stock solutions of the zinc finger peptide in (NH4)CH3COO (5 mm,
pH 7.4) have been prepared as described for the MS samples; com-
pound 3 was dissolved in propionitrile to afford a 3 mm solution
freshly prepared prior to analysis. The evolution of the CD spectra
of the peptide [25 mm in (NH4)CH3COO, 5 mm, pH 7.4] in the pres-
ence of 3 equiv of 3 was followed over time (0, 10, 30, and
60 min). CD spectra were recorded with an Applied Photophysic
Chirascan spectrometer, from 205 to 300 nm by using the follow-
ing parameters: temperature: 25 8C; step size: 1 nm; bandwidth:
1 nm; time per point: 0.5 s; repeat: 4.
Computational studies
DFT calculations were performed on the structures of compounds
1–4 and on the species involved in the reaction pathway of the
title reaction (see Scheme 1) by following recently reported proce-
dures.[10, 20] The M06-L DFT functional,[25] the Lanl2tz(f)[26] basis set
for Au and the 6-31G(d,p)[27] basis set for Cl, S, O, N, C, and H
atoms were used. Solvent effects were implicitly evaluated by full
geometry optimization in the water solvent, reproduced by the po-
larizable continuum model (PCM).[28] Transition-state structures
were found by the synchronous transit guided quasi-Newton
method.[29] Vibration frequency calculations, within the harmonic
approximation, were performed to confirm that each optimized
geometry corresponded to a minimum or to a first-order saddle
point (for transition-state structures) in the potential energy sur-
face, and to evaluate their standard Gibbs free energy values, at
298.15 K. The energy values reported in Figure 3B were obtained
by single point calculations on the optimized structures by using
the Lanl2tz(f) for Au and expanding the all electron basis set to 6-
311G(d,p)[30] for all the other atoms.
Quantum mechanics/molecular mechanics (QM/MM) calculations
were performed to mimic the binding and reactivity of compound
3 with the ZF domain. The ZF model was obtained by the Protein
Data Bank ID: 1MEY, consisting of a crystal structure of a zinc-
finger-DNA complex. In detail, the aminoacidic sequence 32–57
was extracted and residues 45 and 49 changed to K and V, respec-
tively, with the Maestro software,[31] to make the sequence exactly
matching the ZF used in our study. The Zn2+ ion was removed and
the M06-L DFT functional was used in the QM layer (atoms in balls
and sticks in Figure 3C), composed by the Cys35 and Cys38 resi-
dues of the ZF and by the compound 3. The UFF force field[32] was
used in the MM layer (atoms in wires). Full geometry optimization
was followed by a frequency analysis, to confirm that the obtained
structure corresponded to an energy minimum in the potential
energy surface. The transition state structures of the 3-ZF complex
were found by a partial geometry optimization procedure within
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the QM/MM method. In detail, the N@Au and S@Au distances in
TS1, and S@C distance in TS2, were kept constant at the same
values obtained in TS1 and TS2 for compound 3, All calculations
were performed by the Gaussian 09 program package.[33]
Non covalent interactions on the intermediates I of 2 and 3 were
evaluated by using the NCIPLOT program package.[34] Natural Bond
Orbital (NBO) population analysis was performed on the reagents
R of 2 and 3 by using the NBO subroutine[35] implemented in
Gaussian 09. NBO and NCI pictures (Figure S11 and S12, respective-
ly) were reproduced with the Avogadro[36] and VMD[37] software, re-
spectively.
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